Nancy Ryan Gray Ligand Pharmaceuticals Inc (LGND) insider trading activity

Nancy Ryan Gray is Director of LIGAND PHARMACEUTICALS INC. Currently has a direct ownership of 8,094 shares of LGND, which is worth approximately $1.63 Million. The most recent transaction as insider was on Nov 07, 2025, when has been sold 6,571 shares (Common Stock) at a price of $205.45 per share, resulting in proceeds of $1,350,011. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.09K

0% 3M change

17.56% 12M change

Total Value Held $1.63 Million

Nancy Ryan Gray Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 07 2025	SELL Open market or private sale	$1,350,011 $205.45 p/Share	6,571 Reduced 44.81%	8,094 Common Stock
Nov 07 2025	BUY Exercise of conversion of derivative security	$459,181 $69.88 p/Share	6,571 Added 37.17%	11,109 Common Stock
Jun 06 2025	BUY Grant, award, or other acquisition	-	1,209 Added 13.0%	8,094 Common Stock
Jun 14 2024	BUY Grant, award, or other acquisition	-	1,252 Added 15.39%	6,885 Common Stock
May 09 2024	SELL Open market or private sale	$77,708 $83.2 p/Share	934 Reduced 14.22%	5,633 Common Stock
Jun 09 2023	BUY Grant, award, or other acquisition	-	1,142 Added 14.81%	6,567 Common Stock
Jun 10 2022	BUY Grant, award, or other acquisition	-	1,004 Added 17.58%	4,706 Common Stock

Jun 04 2021	BUY Grant, award, or other acquisition	-	630 Added 14.54%	3,702 Common Stock

NRG

Nancy Ryan Gray

Director

Emeryville, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LGND shares.

Notify only if

Value

Insider Trading

Get notified when an Ligand Pharmaceuticals Inc insider buys or sells LGND shares.

Notify only if

Operation

Value

Type

News

Receive news related to LIGAND PHARMACEUTICALS INC

Track Activities on LGND

Account